Metraipolis › archive › dc_c990fb5ec562

Synthesis and characterization of bevacizumab-functionalized nanoliposomes loaded with regorafenib and fluorescent carbon dots for triple-negative breast… — Europe PMC PMID:42211385

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42211385
DOI
10.1039/d6ra03364d
License (as archived)
solo-consultazione
Archived
2026-11-01T07:10:33.632Z
SHA-256 of the archived text
63efd925cba62f40de3ba6fa11ca6ef21e8ebf25e3da179db3bdaa554e5c8dbb
Stable URL of this page
https://metraipolis.com/documento/dc_c990fb5ec562

How to cite

Synthesis and characterization of bevacizumab-functionalized nanoliposomes loaded with regorafenib and fluorescent carbon dots for triple-negative breast… — Europe PMC PMID:42211385 — Europe PMC (en), https://europepmc.org/article/MED/42211385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c990fb5ec562 (Metraipolis archive dc_c990fb5ec562, sha256 63efd925cba62f40de3ba6fa11ca6ef21e8ebf25e3da179db3bdaa554e5c8dbb)
BibTeX
@misc{dcc990fb5ec562,
  title = {Synthesis and characterization of bevacizumab-functionalized nanoliposomes loaded with regorafenib and fluorescent carbon dots for triple-negative breast… — Europe PMC PMID:42211385},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42211385},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c990fb5ec562; sha256 63efd925cba62f40de3ba6fa11ca6ef21e8ebf25e3da179db3bdaa554e5c8dbb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211385. Agents can read the archived copy with the MCP tool read_document.